EDGAR Filing Documents for 0001104659-20-006109

Form 8-K - Current report:

SEC Accession No. 0001104659-20-006109

Filing Date

2020-01-23

Accepted

2020-01-23 09:27:33

Documents

Period of Report

2020-01-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm205593d1_8k.htm	8-K	31828
2	EXHIBIT 3.1	tm205593d1_ex3-1.htm	EX-3.1	93124
3	EXHIBIT 4.1	tm205593d1_ex4-1.htm	EX-4.1	110483
4	EXHIBIT 5.1	tm205593d1_ex5-1.htm	EX-5.1	19288
5	EXHIBIT 10.1	tm205593d1_ex10-1.htm	EX-10.1	193289
6	EXHIBIT 10.2	tm205593d1_ex10-2.htm	EX-10.2	34668
7	EXHIBIT 99.1	tm205593d1_ex99-1.htm	EX-99.1	8881
8	GRAPHIC	ex3-1_image001.jpg	GRAPHIC	72082
9	GRAPHIC	image_001.jpg	GRAPHIC	4802
	Complete submission text file	0001104659-20-006109.txt		599176

Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005

Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)